Articles

CLLS Stock Earnings: Cellectis Beats EPS, Beats Revenue for Q1 2024

CLLS stock results show that Cellectis beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More 

The All-Weather ETF Trifecta: 3 Funds to Buy and Hold Forever

These long-term ETfs to buy and hold offer exposure to the best-performing market segments with improved diversification to boot. More 

$10K Slam Dunks: 3 Stocks to Buy Without Hesitation

These three companies are dead-simple top stocks to buy for a raging bull market showing no sign of letting up. More 

Quant Ratings Updated on 96 Stocks

In today’s Market 360, we’ll preview what to expect from the upcoming PCE report. We’ll also discuss why April’s numbers are particularly important as the Federal Reserve mulls over potential key interest rate cuts later this year. Then, I’ll share how you can prepare for potential volatility ahead by ensuring that your portfolio is full of fundamentally superior stocks... More 

If You Can Only Buy One Growth Stock in May, It Better Be One of These 3 Names

Growth stocks are great for investors who can manage a portfolio with added risk due to inherent stock volatility. More 

3 Sorry Green Energy Stocks to Sell in May While You Still Can

The renewable energy boom has slowed down dramatically over the past year. These three green energy stocks are in particular trouble. More 

7 Dividend Aristocrats Down 12% (or More) That You’ll Regret NOT Buying on the Dip

Despite the deep discounts, these Dividend Aristocrats will soon prove why they are have become income stock royalty. More 

More Articles
Previous Page